APA (7th ed.) Citation

Emami, Z., Shobeiri, S. S., Khorrami, R., Haghnavaz, N., Rezaee, M. A., Moghadam, M., . . . Zimetti, F. (2024). Evaluation of Kynu, Defb2, Camp, and Penk Expression Levels as Psoriasis Marker in the Imiquimod‐Induced Psoriasis Model. Mediators of Inflammation, 2024, 1. https://doi.org/10.1155/2024/5821996

Chicago Style (17th ed.) Citation

Emami, Zahra, Saeideh Sadat Shobeiri, Razia Khorrami, Navideh Haghnavaz, Mohammad Ali Rezaee, Malihe Moghadam, Safoora Pordel, Mojtaba Sankian, and Francesca Zimetti. "Evaluation of Kynu, Defb2, Camp, and Penk Expression Levels as Psoriasis Marker in the Imiquimod‐Induced Psoriasis Model." Mediators of Inflammation 2024 (2024): 1. https://doi.org/10.1155/2024/5821996.

MLA (9th ed.) Citation

Emami, Zahra, et al. "Evaluation of Kynu, Defb2, Camp, and Penk Expression Levels as Psoriasis Marker in the Imiquimod‐Induced Psoriasis Model." Mediators of Inflammation, vol. 2024, 2024, p. 1, https://doi.org/10.1155/2024/5821996.